Series date: 
12/01/2024 - 12:00am CST to 12/31/2025 - 11:59pm CST

This activity is designed for physicians, APPs, nurses, pharmacists and other and healthcare professionals involved in the care of transplantation and cellular therapy patients. The program aims to enhance participants' understanding of both commercial and clinical trial initiatives in transplantation and cellular therapy, as well as current treatment options and professional practice guidelines. Participants will learn to apply new treatment knowledge, integrate practice guidelines into their work, and evaluate the scientific merit of clinical trials in this field.

Course Director:

  • Greg Knight, MD
  • Michael Grunwald, MD

  
Overall Objectives:

  1. Apply knowledge of new treatments emerging in the transplant and cellular therapy field 
  2. Integrate professional practice guidelines into practice
  3. Evaluate scientific merit of transplant and cellular therapy clinical trials

Target Audience:  
This activity is designed for physicians, nursing, and other healthcare professionals.

 

Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) 
Advocate Health designates this live activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

Series location: 
Hybrid
United States